Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users

Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore;...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS and behavior 2005-09, Vol.9 (3), p.301-309
Hauptverfasser: Golub, Elizabeth T, Purvis, Lisa A, Sapun, Marcella, Safaeian, Mahboobeh, Beyrer, Chris, Vlahov, David, Strathdee, Steffanie A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 309
container_issue 3
container_start_page 301
container_title AIDS and behavior
container_volume 9
creator Golub, Elizabeth T
Purvis, Lisa A
Sapun, Marcella
Safaeian, Mahboobeh
Beyrer, Chris
Vlahov, David
Strathdee, Steffanie A
description Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.
doi_str_mv 10.1007/s10461-005-9004-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57202552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>923938571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhkVJadK0P6CXIHLoTe1Isr6OYUmbwEIvoVehlceuFq-8keyE_vva7EKhl55mYJ73heEh5BOHLxzAfK0cGs0ZgGIOoGHyDbniykgmhWoulh0cMMO1uiTva90DgNPGvSOXXIO1UusrEje_Qu6x0pTpaxqGlPuMtdJppMdQphTTMUy4Xh8ef9KXEGPKSKeSwlBpOIy5Xw8sYx-m9LKCe4xTGjNty9zTuWKpH8jbbsHx43lek6dv90-bB7b98f1xc7dlUVo7sQYtN7hD0wZEY1DulG1EaEGBiKozRjm5i53pYmNRywbQ2VbExrXOCnTymnw-1R7L-Dxjnfwh1YjDEDKOc_XKCBBKif-C3AhutIAFvP0H3I9zycsPXnDOnQYhF4ifoFjGWgt2_ljSIZTfnoNfNfmTJr9o8qsmv2ZuzsXz7oDt38TZi_wDsaONVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211196023</pqid></control><display><type>article</type><title>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</title><source>MEDLINE</source><source>Sociological Abstracts</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>SpringerLink Journals (MCLS)</source><creator>Golub, Elizabeth T ; Purvis, Lisa A ; Sapun, Marcella ; Safaeian, Mahboobeh ; Beyrer, Chris ; Vlahov, David ; Strathdee, Steffanie A</creator><creatorcontrib>Golub, Elizabeth T ; Purvis, Lisa A ; Sapun, Marcella ; Safaeian, Mahboobeh ; Beyrer, Chris ; Vlahov, David ; Strathdee, Steffanie A</creatorcontrib><description>Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.</description><identifier>ISSN: 1090-7165</identifier><identifier>EISSN: 1573-3254</identifier><identifier>DOI: 10.1007/s10461-005-9004-3</identifier><identifier>PMID: 16088366</identifier><identifier>CODEN: AIBEFC</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Acquired immune deficiency syndrome ; Adult ; AIDS ; AIDS Serodiagnosis ; AIDS Vaccines - administration &amp; dosage ; Clinical trials ; Clinical Trials as Topic ; Drug abusers ; Epidemiology ; Female ; Financial incentives ; HIV ; HIV Infections - diagnosis ; HIV Infections - prevention &amp; control ; Human immunodeficiency virus ; Humans ; Injection ; Interviews as Topic ; Logistic Models ; Male ; Patient Participation - psychology ; Prevention ; Prospective Studies ; Public health ; Questionnaires ; Substance Abuse, Intravenous - complications ; Surveys and Questionnaires ; Vaccines ; Willingness</subject><ispartof>AIDS and behavior, 2005-09, Vol.9 (3), p.301-309</ispartof><rights>Springer Science+Business Media, Inc. 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</citedby><cites>FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27344,27924,27925,31000,33774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16088366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golub, Elizabeth T</creatorcontrib><creatorcontrib>Purvis, Lisa A</creatorcontrib><creatorcontrib>Sapun, Marcella</creatorcontrib><creatorcontrib>Safaeian, Mahboobeh</creatorcontrib><creatorcontrib>Beyrer, Chris</creatorcontrib><creatorcontrib>Vlahov, David</creatorcontrib><creatorcontrib>Strathdee, Steffanie A</creatorcontrib><title>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</title><title>AIDS and behavior</title><addtitle>AIDS Behav</addtitle><description>Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>AIDS</subject><subject>AIDS Serodiagnosis</subject><subject>AIDS Vaccines - administration &amp; dosage</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic</subject><subject>Drug abusers</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Financial incentives</subject><subject>HIV</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - prevention &amp; control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Injection</subject><subject>Interviews as Topic</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Patient Participation - psychology</subject><subject>Prevention</subject><subject>Prospective Studies</subject><subject>Public health</subject><subject>Questionnaires</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Surveys and Questionnaires</subject><subject>Vaccines</subject><subject>Willingness</subject><issn>1090-7165</issn><issn>1573-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>BHHNA</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkU1r3DAQhkVJadK0P6CXIHLoTe1Isr6OYUmbwEIvoVehlceuFq-8keyE_vva7EKhl55mYJ73heEh5BOHLxzAfK0cGs0ZgGIOoGHyDbniykgmhWoulh0cMMO1uiTva90DgNPGvSOXXIO1UusrEje_Qu6x0pTpaxqGlPuMtdJppMdQphTTMUy4Xh8ef9KXEGPKSKeSwlBpOIy5Xw8sYx-m9LKCe4xTGjNty9zTuWKpH8jbbsHx43lek6dv90-bB7b98f1xc7dlUVo7sQYtN7hD0wZEY1DulG1EaEGBiKozRjm5i53pYmNRywbQ2VbExrXOCnTymnw-1R7L-Dxjnfwh1YjDEDKOc_XKCBBKif-C3AhutIAFvP0H3I9zycsPXnDOnQYhF4ifoFjGWgt2_ljSIZTfnoNfNfmTJr9o8qsmv2ZuzsXz7oDt38TZi_wDsaONVg</recordid><startdate>200509</startdate><enddate>200509</enddate><creator>Golub, Elizabeth T</creator><creator>Purvis, Lisa A</creator><creator>Sapun, Marcella</creator><creator>Safaeian, Mahboobeh</creator><creator>Beyrer, Chris</creator><creator>Vlahov, David</creator><creator>Strathdee, Steffanie A</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7T2</scope><scope>7U3</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AM</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>BHHNA</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HEHIP</scope><scope>K7.</scope><scope>K9.</scope><scope>KB0</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7QJ</scope></search><sort><creationdate>200509</creationdate><title>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</title><author>Golub, Elizabeth T ; Purvis, Lisa A ; Sapun, Marcella ; Safaeian, Mahboobeh ; Beyrer, Chris ; Vlahov, David ; Strathdee, Steffanie A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>AIDS</topic><topic>AIDS Serodiagnosis</topic><topic>AIDS Vaccines - administration &amp; dosage</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic</topic><topic>Drug abusers</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Financial incentives</topic><topic>HIV</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - prevention &amp; control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Injection</topic><topic>Interviews as Topic</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Patient Participation - psychology</topic><topic>Prevention</topic><topic>Prospective Studies</topic><topic>Public health</topic><topic>Questionnaires</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Surveys and Questionnaires</topic><topic>Vaccines</topic><topic>Willingness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golub, Elizabeth T</creatorcontrib><creatorcontrib>Purvis, Lisa A</creatorcontrib><creatorcontrib>Sapun, Marcella</creatorcontrib><creatorcontrib>Safaeian, Mahboobeh</creatorcontrib><creatorcontrib>Beyrer, Chris</creatorcontrib><creatorcontrib>Vlahov, David</creatorcontrib><creatorcontrib>Strathdee, Steffanie A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Social Services Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Criminology Collection</collection><collection>Sociological Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Sociology Collection</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Criminal Justice Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest research library</collection><collection>Sociology Database (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>AIDS and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golub, Elizabeth T</au><au>Purvis, Lisa A</au><au>Sapun, Marcella</au><au>Safaeian, Mahboobeh</au><au>Beyrer, Chris</au><au>Vlahov, David</au><au>Strathdee, Steffanie A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</atitle><jtitle>AIDS and behavior</jtitle><addtitle>AIDS Behav</addtitle><date>2005-09</date><risdate>2005</risdate><volume>9</volume><issue>3</issue><spage>301</spage><epage>309</epage><pages>301-309</pages><issn>1090-7165</issn><eissn>1573-3254</eissn><coden>AIBEFC</coden><abstract>Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16088366</pmid><doi>10.1007/s10461-005-9004-3</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1090-7165
ispartof AIDS and behavior, 2005-09, Vol.9 (3), p.301-309
issn 1090-7165
1573-3254
language eng
recordid cdi_proquest_miscellaneous_57202552
source MEDLINE; Sociological Abstracts; Applied Social Sciences Index & Abstracts (ASSIA); SpringerLink Journals (MCLS)
subjects Acquired immune deficiency syndrome
Adult
AIDS
AIDS Serodiagnosis
AIDS Vaccines - administration & dosage
Clinical trials
Clinical Trials as Topic
Drug abusers
Epidemiology
Female
Financial incentives
HIV
HIV Infections - diagnosis
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Injection
Interviews as Topic
Logistic Models
Male
Patient Participation - psychology
Prevention
Prospective Studies
Public health
Questionnaires
Substance Abuse, Intravenous - complications
Surveys and Questionnaires
Vaccines
Willingness
title Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20willingness%20to%20participate%20in%20HIV%20vaccine%20trials%20among%20HIV-negative%20injection%20drug%20users&rft.jtitle=AIDS%20and%20behavior&rft.au=Golub,%20Elizabeth%20T&rft.date=2005-09&rft.volume=9&rft.issue=3&rft.spage=301&rft.epage=309&rft.pages=301-309&rft.issn=1090-7165&rft.eissn=1573-3254&rft.coden=AIBEFC&rft_id=info:doi/10.1007/s10461-005-9004-3&rft_dat=%3Cproquest_cross%3E923938571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211196023&rft_id=info:pmid/16088366&rfr_iscdi=true